128 related articles for article (PubMed ID: 3484629)
1. The binding of the calcium channel blocker, bepridil, to calmodulin.
Itoh H; Tanaka T; Mitani Y; Hidaka H
Biochem Pharmacol; 1986 Jan; 35(2):217-20. PubMed ID: 3484629
[TBL] [Abstract][Full Text] [Related]
2. Effects on calmodulin of bepridil, an antianginal agent.
Itoh H; Ishikawa T; Hidaka H
J Pharmacol Exp Ther; 1984 Sep; 230(3):737-41. PubMed ID: 6088765
[TBL] [Abstract][Full Text] [Related]
3. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
Lamers JM; Cysouw KJ; Verdouw PD
Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of the drug-binding sites of calmodulin.
Zimmer M; Hofmann F
Eur J Biochem; 1987 Apr; 164(2):411-20. PubMed ID: 3032617
[TBL] [Abstract][Full Text] [Related]
5. Interaction of calmodulin and calcium antagonists with [3H]diltiazem and [3H]nitrendipine binding sites.
Schaeffer P; Lugnier C; Stoclet JC
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S102-3. PubMed ID: 2468847
[TBL] [Abstract][Full Text] [Related]
6. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
Agre P; Virshup D; Bennett V
J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
[TBL] [Abstract][Full Text] [Related]
7. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
Balwierczak JL; Johnson CL; Schwartz A
Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
Galizzi JP; Fosset M; Lazdunski M
Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
[TBL] [Abstract][Full Text] [Related]
9. Interactions of calmodulin antagonists with calcium antagonists binding sites.
Schaeffer P; Lugnier C; Stoclet JC
Eur J Pharmacol; 1991 Apr; 206(4):325-32. PubMed ID: 1655490
[TBL] [Abstract][Full Text] [Related]
10. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
Walsh MP; Sutherland C; Scott-Woo GC
Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
[TBL] [Abstract][Full Text] [Related]
11. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Yamakado T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
[TBL] [Abstract][Full Text] [Related]
12. The effects of bepridil, compared with calcium-channel inhibitors and calmodulin antagonists on both spontaneous activity and contractions induced by potassium or phenylephrine in rat portal vein.
Campbell JK; Winslow E; Marshall RJ
Eur J Pharmacol; 1986 Dec; 132(2-3):187-96. PubMed ID: 3493163
[TBL] [Abstract][Full Text] [Related]
13. The effects of felodipine and bepridil on calcium-stimulated calmodulin binding and calcium pumping ATPase of cardiac sarcolemma before and after removal of endogenous calmodulin.
Lamers JM; Verdouw PD; Mas-Oliva J
Mol Cell Biochem; 1987 Dec; 78(2):169-76. PubMed ID: 2964559
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of cardiac myofilament force, ATPase activity and troponin C Ca++ binding by bepridil.
Solaro RJ; Bousquet P; Johnson JD
J Pharmacol Exp Ther; 1986 Aug; 238(2):502-7. PubMed ID: 2942677
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
Tanaka M; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
[TBL] [Abstract][Full Text] [Related]
16. Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.
Pang DC; Sperelakis N
Eur J Pharmacol; 1983 Feb; 87(2-3):199-207. PubMed ID: 6601581
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin activates bovine-cardiac myosin light-chain kinase by increasing the affinity for myosin light-chain 2.
Zimmer M; Göbel C; Hofmann F
Eur J Biochem; 1984 Mar; 139(2):295-301. PubMed ID: 6546546
[TBL] [Abstract][Full Text] [Related]
18. Calponin-calmodulin interaction: properties and effects on smooth and skeletal muscle actin binding and actomyosin ATPases.
Winder SJ; Walsh MP; Vasulka C; Johnson JD
Biochemistry; 1993 Dec; 32(48):13327-33. PubMed ID: 8241189
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of the calmodulin antagonist bepridil on ischaemia induced in the rat myocardium.
Shikano K; Kusagawa M; Itoh H; Hidaka H
Cardiovasc Res; 1986 May; 20(5):364-8. PubMed ID: 3019548
[TBL] [Abstract][Full Text] [Related]
20. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
Galizzi JP; Fosset M; Lazdunski M
Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
